Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy (Q28235277)
scientific article (publication date: 26 April 2011)
Language:
(P31) (Q13442814)
(P50) (Q42315566)
(Q38544864)
(Q89299610)
(P304) 7142-7
(P407) (Q1860)
(P433) 17
(P478) 108
(P577) Tuesday, April 26, 2011
(P1433) (Q1146531)
(P1476) "Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy" (language: en)
(P2093) John Stagg
Upulie Divisekera
Shin Foong Ngiow
Helene Duret
Michele W Teng
(P2860) (Q28140238)
(Q29615665)
(Q29615810)
(Q29620051)
(Q34073138)
(Q39702445)
(Q37626334)
(Q36945070)
(Q34592058)
(Q36532521)
(Q40001571)
(Q36392969)
(Q36465344)
(Q36845184)
(Q40282761)
(Q36613598)
(Q35164084)
(Q42810747)
(Q43121691)
(Q46891052)
(Q51888516)
(Q51730682)
(Q47587986)
(Q46362046)
(Q77948519)
(Q81038993)
(Q62604205)
(Q60489482)
(Q62604209)
(Q60489570)
(Q79979044)
(Q80427857)
(Q73110180)
other details
description scientific article (publication date: 26 April 2011)

External Links